These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
174 related items for PubMed ID: 16930563
1. Fluorinated Cpd 5, a pure arylating K-vitamin derivative, inhibits human hepatoma cell growth by inhibiting Cdc25 and activating MAPK. Kar S, Wang M, Ham SW, Carr BI. Biochem Pharmacol; 2006 Nov 15; 72(10):1217-27. PubMed ID: 16930563 [Abstract] [Full Text] [Related]
2. H32, a non-quinone sulfone analog of vitamin K3, inhibits human hepatoma cell growth by inhibiting Cdc25 and activating ERK. Kar S, Wang M, Ham SW, Carr BI. Cancer Biol Ther; 2006 Oct 15; 5(10):1340-7. PubMed ID: 16969075 [Abstract] [Full Text] [Related]
3. Hepatocyte growth factor enhances protein phosphatase Cdc25A inhibitor compound 5-induced hepatoma cell growth inhibition via Akt-mediated MAPK pathway. Wang Z, Wang M, Carr BI. J Cell Physiol; 2005 Jun 15; 203(3):510-9. PubMed ID: 15534860 [Abstract] [Full Text] [Related]
4. K vitamins, PTP antagonism, and cell growth arrest. Carr BI, Wang Z, Kar S. J Cell Physiol; 2002 Dec 15; 193(3):263-74. PubMed ID: 12384979 [Abstract] [Full Text] [Related]
6. 2-Methoxyestradiol inhibits hepatocellular carcinoma cell growth by inhibiting Cdc25 and inducing cell cycle arrest and apoptosis. Kar S, Wang M, Carr BI. Cancer Chemother Pharmacol; 2008 Oct 15; 62(5):831-40. PubMed ID: 18246350 [Abstract] [Full Text] [Related]
9. Involvement of Cdc25A phosphatase in Hep3B hepatoma cell growth inhibition induced by novel K vitamin analogs. Wang Z, Southwick EC, Wang M, Kar S, Rosi KS, Wilcox CS, Lazo JS, Carr BI. Cancer Res; 2001 Oct 01; 61(19):7211-6. PubMed ID: 11585757 [Abstract] [Full Text] [Related]
12. Cdc25A and ERK interaction: EGFR-independent ERK activation by a protein phosphatase Cdc25A inhibitor, compound 5. Wang Z, Zhang B, Wang M, Carr BI. J Cell Physiol; 2005 Aug 01; 204(2):437-44. PubMed ID: 15672448 [Abstract] [Full Text] [Related]
13. Inhibition of rat liver regeneration after partial hepatectomy and induction of ERK phosphorylation by Cpd 5, a K vitamin-based anticancer compound. Kar S, Wang M, Rosi KS, Wilcox CS, Carr BI. Carcinogenesis; 2004 Dec 01; 25(12):2345-51. PubMed ID: 15319298 [Abstract] [Full Text] [Related]
15. Grb2-associated binder-1 plays a central role in the hepatocyte growth factor enhancement of hepatoma growth inhibition by K vitamin analog compound 5. Wang Z, Ge L, Wang M, Carr BI. Hepatology; 2007 Dec 01; 46(6):2003-13. PubMed ID: 18046719 [Abstract] [Full Text] [Related]
18. Indomethacin induces apoptosis in 786-O renal cell carcinoma cells by activating mitogen-activated protein kinases and AKT. Ou YC, Yang CR, Cheng CL, Raung SL, Hung YY, Chen CJ. Eur J Pharmacol; 2007 Jun 01; 563(1-3):49-60. PubMed ID: 17341418 [Abstract] [Full Text] [Related]
19. Tumor cell growth inhibition and extracellular signal-regulated kinase (ERK) phosphorylation by novel K vitamins. Osada S, Osada K, Carr BI. J Mol Biol; 2001 Dec 07; 314(4):765-72. PubMed ID: 11733995 [Abstract] [Full Text] [Related]
20. Modulation of arsenic trioxide-induced apoptosis by genistein and functionally related agents in U937 human leukaemia cells. Regulation by ROS and mitogen-activated protein kinases. Sánchez Y, Calle C, de Blas E, Aller P. Chem Biol Interact; 2009 Nov 10; 182(1):37-44. PubMed ID: 19720055 [Abstract] [Full Text] [Related] Page: [Next] [New Search]